From: The efficacy of iron chelator regimes in reducing cardiac and hepatic iron in patients with thalassaemia major: a clinical observational study
Medication
DFP
Comb
DFX
DFO
Total
Fall < 9, n (%)
Unchanged, n (%)
7 (50)
32 (94)
4 (40)
8 (66.7)
51 (73)
Total, n (%)
14 (100)
34 (100)
10 (100)
12 (100)
70 (100)